Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The rationale for combination therapy.

E G Evans1

  • 1Mycology Reference Centre, Division of Microbiology, University of Leeds, UK. e.g.v.evans@leeds.ac.uk

The British Journal of Dermatology
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-traumatic fungal keratitis caused by Absidia corymbifera, with successful medical treatment.

Eye (London, England)·2001
Same author

A two year global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion.

Diagnostic microbiology and infectious disease·2001
Same author

An investigation into the pathogenesis of vulvo-vaginal candidosis.

Sexually transmitted infections·2001
Same author

Vaginal yeasts in the era of "over the counter" antifungals.

Sexually transmitted infections·2001
Same author

Training medical myocologists in developing countries.

Medical mycology·2001
Same author

Current and future approaches to antimycotic treatment in the era of resistant fungi and immunocompromised hosts.

International journal of antimicrobial agents·2001
Same journal

Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials.

The British journal of dermatology·2026
Same journal

Clinicopathological features of lymphocytic thrombophilic arteritis and the relationship with livedoid vasculopathy - a case series of 36 patients.

The British journal of dermatology·2026
Same journal

Improving Prognostication for Cutaneous Squamous Cell Carcinoma.

The British journal of dermatology·2026
Same journal

Recurrent and novel GLTP variants in five patients with nonsyndromic epidermal differentiation disorder: phenotypic and genotypic expansion.

The British journal of dermatology·2026
Same journal

Sustained efficacy of dupilumab in pediatric patients with moderate-to-severe atopic dermatitis over 1 year.

The British journal of dermatology·2026
Same journal

EPHX3-nEDD: from molecular diagnosis to epidermal lipid biology.

The British journal of dermatology·2026
See all related articles

Nail fungal infections, often caused by Trichophyton rubrum, frequently resist treatment. Understanding underlying mechanisms and identifying poor prognostic indicators are crucial for developing new therapies to improve cure rates.

Area of Science:

  • Mycology
  • Dermatology
  • Infectious Diseases

Background:

  • Fungal nail infections are prevalent in Europe, commonly caused by dermatophytes like Trichophyton rubrum.
  • Current treatments are often effective but have a significant failure or relapse rate (20-30%).
  • Limited understanding of nail fungal infection pathophysiology hinders the development of novel therapeutic strategies.

Purpose of the Study:

  • To highlight the challenges in treating fungal nail infections.
  • To emphasize the need for better diagnostic and prognostic tools.
  • To explore potential advancements in treatment modalities.

Main Methods:

  • Review of current literature on fungal nail infections.
  • Analysis of factors contributing to treatment resistance.

Related Experiment Videos

  • Discussion of emerging research directions.

    • Main Results:

    • Treatment failure and relapse rates remain high despite available therapies.
    • Patient susceptibility, fungal resistance, and dormant spores (arthrospores) contribute to recalcitrant infections.
    • Research is focusing on identifying poor prognostic indicators and synergistic drug combinations.

    Conclusions:

    • Accurate diagnosis is essential for effective treatment of fungal nail infections.
    • Further research into pathophysiological mechanisms is needed to overcome treatment resistance.
    • Developing new strategies, such as combination therapies, may improve cure rates for difficult-to-treat cases.